This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Income
$111.4M
Filings
2,219
Unique Clients
48
Active Period
2002–2026
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Alternatives to PAIN Act
2026 · third_quarter · Client: VERTEX PHARMACEUTICALS INCORPORATED
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1227
Alternatives to PAIN Act
2026 · third_quarter · Client: VERTEX PHARMACEUTICALS INCORPORATED
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language
Client expense: — · Firm income: $60,000
Matched citations: S. 475
Patients Deserve Price Tags Act
2026 · third_quarter · Client: UNITEDHEALTH GROUP, INC.
H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Client expense: — · Firm income: $120,000
Matched citations: H.R. 5582
Lower Costs, More Transparency Act of 2026
2026 · third_quarter · Client: UNITEDHEALTH GROUP, INC.
H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Client expense: — · Firm income: $120,000
Matched citations: H.R. 9393
Tax Exempt Hospital Transparency Act
2026 · third_quarter · Client: UNITEDHEALTH GROUP, INC.
H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Client expense: — · Firm income: $120,000
Matched citations: H.R. 9504
Issues relating to Medicare Advantage; Issues related to the use of AI and its correlation to prior authorization and utilization management policies; S. 1105, No UPCODE Act; Issues related to Senate Finance Dear Colleague process
Client expense: — · Firm income: $120,000
Matched citations: S. 1105
Patients Deserve Price Tags Act
2026 · third_quarter · Client: UNITEDHEALTH GROUP, INC.
H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act; Issues related to surprise medical billing
Client expense: — · Firm income: $120,000
Matched citations: S. 2355
Protecting Patient Access to Cancer and Complex Therapies Act
2026 · third_quarter · Client: TAKEDA PHARMACEUTICALS AMERICA, INC.
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4299
To amend title XVIII to reform the Medicare Advantage program.
2026 · third_quarter · Client: SNP ALLIANCE INC
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star Ratings
Client expense: — · Firm income: $50,000
Matched citations: H.R. 3467
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star Ratings
Client expense: — · Firm income: $50,000
Matched citations: S. 1105
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · third_quarter · Client: SIEMENS MEDICAL SOLUTIONS USA, INC
Monitor issues related to physician payment cuts; Monitor issues related to clinical lab tests; H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process; S. 1399, Health Tech Investment Act
Client expense: — · Firm income: $70,000
Matched citations: H.R. 5343
Health Tech Investment Act
2026 · third_quarter · Client: SIEMENS MEDICAL SOLUTIONS USA, INC
Issues related to healthcare data privacy; Issues related to Artificial Intelligence within the healthcare sector; H.R. 6197/S. 1399, Health Tech Investment Act
Client expense: — · Firm income: $70,000
Matched citations: H.R. 6197
Health Tech Investment Act
2026 · third_quarter · Client: SIEMENS MEDICAL SOLUTIONS USA, INC
Issues related to healthcare data privacy; Issues related to Artificial Intelligence within the healthcare sector; H.R. 6197/S. 1399, Health Tech Investment Act
Client expense: — · Firm income: $70,000
Matched citations: S. 1399
Health Tech Investment Act
2026 · third_quarter · Client: SIEMENS MEDICAL SOLUTIONS USA, INC
Monitor issues related to physician payment cuts; Monitor issues related to clinical lab tests; H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process; S. 1399, Health Tech Investment Act
Client expense: — · Firm income: $70,000
Matched citations: S. 1399
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · third_quarter · Client: SIEMENS MEDICAL SOLUTIONS USA, INC
Monitor issues related to physician payment cuts; Monitor issues related to clinical lab tests; H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process; S. 1399, Health Tech Investment Act
Client expense: — · Firm income: $70,000
Matched citations: S. 1717
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Client expense: — · Firm income: $50,000
Matched citations: S. 1105
Priority for Pediatric Cures Act
2026 · third_quarter · Client: OMEROS CORPORATION
Issues related to Pediatric Review Voucher (PRV); H.R. 10359, Priority for Pediatric Cures Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 10359
To amend title XVIII to reform the Medicare Advantage program.
2026 · third_quarter · Client: NATIONAL ALLIANCE FOR CARE AT HOME
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3467
Home Health Stabilization Act of 2025
2026 · third_quarter · Client: NATIONAL ALLIANCE FOR CARE AT HOME
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5142
Medicare Advantage Improvement Act of 2026
2026 · third_quarter · Client: NATIONAL ALLIANCE FOR CARE AT HOME
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Client expense: — · Firm income: $60,000
Matched citations: H.R. 8375
Protecting Seniors and Stopping Fraudsters Act
2026 · third_quarter · Client: NATIONAL ALLIANCE FOR CARE AT HOME
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Client expense: — · Firm income: $60,000
Matched citations: H.R. 8883
Medicare Advantage Improvement Act of 2026
2026 · third_quarter · Client: NATIONAL ALLIANCE FOR CARE AT HOME
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Client expense: — · Firm income: $60,000
Matched citations: S. 4384
Medicare Home Health Payment Integrity and Protection Act of 2026
2026 · third_quarter · Client: NATIONAL ALLIANCE FOR CARE AT HOME
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Client expense: — · Firm income: $60,000
Matched citations: S. 5250
Protecting Patient Access to Cancer and Complex Therapies Act
2026 · third_quarter · Client: MERCK & CO., INC.
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to cyclic peptides; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4299
Patients Deserve Price Tags Act
2026 · third_quarter · Client: MARYLAND HOSPITAL ASSOCIATION
Issues related to health workforce, including H1B visa and student loan reform; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5582
Source: Senate LDA